Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e76bed149c9c14aef509272734cba0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0dc88613e868af3393e47f038b192628 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77f8f0c84f00a3d1d8950f724374e3bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a3b3e44e8135be32f2f412425140cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dee986eca9bb84f2ee531849851be2dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a029a992fadf8ff8a2e046c7a857adcc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6a1340a507c59573981f7369dea873d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-18 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-507 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0094 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-06 |
filingDate |
2010-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dea0193ac3396139990d8be9956d888 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c5c1a1a1f7927b7945b01a5cadf7fad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf0bc81a3ea2cb760e2be25c5e44e4cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d372cd331aa91e83035a4a352eb305cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77e23d047b686c2ba4183095f2a0b39c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_588689b0df733ad11fa46372f7c6a943 |
publicationDate |
2011-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2010123465-A3 |
titleOfInvention |
Method for the treatment of biomedical polymeric implants for the improvement of antithrombogenic properties thereof |
abstract |
The subject of the invention is a method for the treatment of biomedical implants for the improvement of antithrombogenic properties thereof. The mentioned biomedical implants are cardiovascular implants, especially artificial blood vessels and stents made from a polyethyleneterephtalate (PET) polymer. The method is based on the treatment of a surface of cardiovascular implants by an adequate combination of a dose of neutral oxygen atom and positively charged molecular and atomic oxygen ions. After having been treated by a dose of said atoms and ions, the surface of cardiovascular implants becomes less prone to binding of thrombocytes. The method is characterised in that the exposure to a mixture of neutral oxygen atoms and positively charged molecular and atomic oxygen ions in pulses is such that in an individual pulse a dose of neutral oxygen atoms is reached between 10 20 m -2 and 10 26 m -2 , and the dose of charged molecular and atomic oxygen ions between 10 16 m -2 and 10 23 m -2 , the interval between individual pulses is between 10 s and 300 s, and that the flow of neutral oxygen atoms and positively charged molecular and atomic oxygen ions onto the surface of an implant is approximately even. |
priorityDate |
2009-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |